Boostrix is a professional-grade booster vaccine developed by GSK to provide robust, combined protection against three serious bacterial infections: diphtheria, tetanus, and pertussis (whooping cough). Formulated as an adsorbed vaccine with a reduced antigen content (dTpa), it is specifically designed to safely refresh and maintain immunity in older children, adolescents, and adults. Delivered in convenient, single-use 0.5 mL pre-filled syringes for deep intramuscular injection, it effectively stimulates the immune system to defend against cellular toxins without overwhelming the body. This vaccine plays a vital role in public health by preventing community outbreaks and protecting vulnerable populations.